Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy in multiple myeloma--possibility or probability?

S J Harrison1, G Cook

  • 1ATMU and Cancer Division, Section of Experimental Haematology, University of Glasgow, Glasgow, UK.

British Journal of Haematology
|July 27, 2005
PubMed
Summary

Harnessing the immune system shows promise for treating multiple myeloma (MM). Research explores using immune cells like T cells and natural killer cells to achieve long-term remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular characterisation of a novel citrus-infecting emaravirus, citrus emaravirus 1.

Archives of virology·2025
Same author

Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from Regulation.

Plant disease·2025
Same author

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Blood cancer journal·2024
Same author

Population dynamics of a long-term selection experiment in White Plymouth Rock chickens selected for low or high body weight.

Poultry science·2023
Same author

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • Allogeneic stem cell transplantation demonstrates a graft-versus-tumour effect in multiple myeloma (MM).
  • This success fuels research into leveraging the patient's own immune system for cancer eradication.

Purpose of the Study:

  • To review the immunobiology of MM.
  • To assess how immune components like dendritic cells, T cells, and natural killer cells can be utilized in immunotherapy.
  • To evaluate the current status and feasibility of immunotherapy for MM.

Main Methods:

  • Review of current understanding of MM immunobiology.
  • Analysis of in-vitro and in-vivo immune priming techniques.
  • Assessment of reported clinical immunotherapy trials in MM.

Related Experiment Videos

Main Results:

  • The graft-versus-tumour effect offers a potential mechanism for long-term disease control in MM.
  • Various immune cells and priming strategies are being investigated for their therapeutic potential.

Conclusions:

  • Immunotherapy holds promise for MM treatment by directing the patient's immune system against the cancer.
  • Further research and clinical trials are necessary to determine if immunotherapy is an achievable goal for MM eradication.